Stephen Hoge
Stephen Hoge is the President of Moderna, the biotechnology company known for developing mRNA-based medicines and one of the leading COVID-19 vaccines. He joined Moderna in 2012 and has overseen the company's clinical development, regulatory affairs, and commercial operations.
Claims from Stephen Hoge
Stephen Hoge“Having it fully enrolled and knowing the natural history of when we’d expect those events to be, we’re cautiously optimistic ’27 is right on path.”Mar 10, 2025
Controversy:Will FDA Approve a Skin Cancer Vaccine by 2028?